Viewing Study NCT02498522



Ignite Creation Date: 2024-05-06 @ 7:13 AM
Last Modification Date: 2024-10-26 @ 11:46 AM
Study NCT ID: NCT02498522
Status: COMPLETED
Last Update Posted: 2016-05-19
First Post: 2015-07-13

Brief Title: Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome
Sponsor: Ain Shams University
Organization: Ain Shams University

Study Overview

Official Title: Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome
Status: COMPLETED
Status Verified Date: 2016-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MIP
Brief Summary: The aim of this work is to study the effect of metformin use for reducing early pregnancy loss in pregnant patients with Polycystic ovary syndrome PCOS
Detailed Description: Polycystic ovary syndrome PCOS is the most common endocrine disorder in women of reproductive age PCOS produces symptoms in approximately 5 to 10 of women of reproductive age 12-45 years old and is thought to be one of the leading causes of the female subfertility

The aim of this work is to study the effect of metformin use for reducing early pregnancy loss in pregnant patients with PCOS
Research question

In pregnant women with PCOS does metformin use decreases the rate of early pregnancy loss

-Research hypothesis In Pregnant women with PCOS metformin may reduce the rate of early pregnancy loss

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None